Use of psychoactive substances and health care in response to anxiety and depressive disorders

Psychiatric Services

Volumn 60, Issue 3, 2009, Pages 351-357

  Encrenaz, Gaëlle ^a   Kovess Masféty, Viviane ^b   Jutand, Marthe Aline ^c   Carmona, Elodie ^b   Sapinho, David ^b   Messiah, Antoine ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61749091420     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.3.351     Document Type: Article

References (45)

1. Grant BF, Stinson FS, Dawson DA, et al: Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61:807-816, 2004
2. Grant BF, Hasin DS, Stinson FS, et al: The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67:363-374, 2006
3. Kessler RC, Berglund P, Demler O, et al: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:593-602, 2005
4. Kessler RC, Chiu WT, Jin R, et al: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry 63:415-424, 2006
5. Pirkola SP, Isometsa E, Suvisaari J, et al: DSM-IV mood, anxiety and alcohol use disorders and their comorbidity in the Finnish general population: results from the Health 2000 Study. Social Psychiatry and Psychiatric Epidemiology 40:1-10, 2005
6. Sandanger I, Nygard JF, Ingebrigtsen G, et al: Prevalence, incidence and age at onset of psychiatric disorders in Norway. Social Psychiatry and Psychiatric Epidemiology 34:570-579, 1999
7. Karam EG, Mneimneh ZN, Karam AN, et al: Prevalence and treatment of mental disorders in Lebanon: a national epidemiological survey. Lancet 367:1000-1006, 2006
8. Jacobi F, Wittchen HU, Holting C, et al: Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine 34:597-611, 2004
9. Alonso J, Angermeyer MC, Bernert S, et al: Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Suppl 420:21-27, 2004
10. Kohn R, Saxena S, Levav I, et al: The treatment gap in mental health care. Bulletin of the World Health Organization 82:858-866, 2004
11. Kessler RC: Psychiatric epidemiology: selected recent advances and future directions. Bulletin of the World Health Organization 78:464-474, 2000
12. Khantzian EJ: The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry 142:1259-1264, 1985
13. Khantzian EJ: The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 4:231-244, 1997
14. Mueser KT, Drake RE, Wallach MA: Dual diagnosis: a review of etiological theories. Addictive Behaviors 23:717-734, 1998
15. Jorm AF, Medway J, Christensen H, et al: Public beliefs about the helpfulness of interventions for depression: effects on actions taken when experiencing anxiety and depression symptoms. Australian and New Zealand Journal of Psychiatry 34:619-626, 2000
16. Ramage-Morin PL: Panic disorder and coping. Health Reports 15(suppl):31-43, 2004
17. Boys A, Marsden J, Strang J: Understanding reasons for drug use amongst young people: a functional perspective. Health Education Research 16:457-469, 2001
18. Bolton J, Cox B, Clara I, et al: Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. Journal of Nervous and Mental Disease 194:818-825, 2006
19. Blume SB: Gender differences in alcohol-related disorders. Harvard Review of Psychiatry 2:7-14, 1994
20. Encrenaz G, Messiah A: Lifetime psychiatric comorbidity with substance use disorders: does healthcare use modify the strength of associations? Social Psychiatry and Psychiatric Epidemiology 41:378-385, 2006
21. Encrenaz G, Kovess-Masféty V, Sapinho D, et al: Utilization of mental health services and risk of 12-month problematic alcohol use. American Journal of Health Behaviors 31:392-401, 2007
22. Kish L: Survey Sampling. New York, Wiley, 1965
23. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
24. Kessler RC, Andrews G, Mroczek D, et al: The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). International Journal of Methods in Psychiatric Research 7:171-185, 1998
25. Alonso J, Angermeyer MC, Bernert S, et al: Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Suppl 420:8-20, 2004
26. Sheehan DV, Harnett-Sheehan K, Raj BA: The measurement of disability. International Clinical Psychopharmacology 11 (suppl 3):89-95, 1996
27. Stephens T, Dulberg C, Joubert N: Mental health of the Canadian population: a comprehensive analysis. Chronic Diseases in Canada 20:118-126, 1999
28. Lee ES, Forthofer RN, Lorimer RJ: Analysing Complex Survey Data. London, Sage, 1989
29. Hosmer DW, Lemeshow S: Applied Logistic Regression, 2nd ed. New York, Wiley, 2000
30. Verdoux H: The current state of adult mental health care in France. European Archives of Psychiatry and Clinical Neuroscience 257:64-70, 2007
31. Verdoux H, Tignol J: Focus on psychiatry in France. British Journal of Psychiatry 183:466-471, 2003
32. Kessler RC, McGonagle KA, Zhao S, et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 51:8-19, 1994
33. Alonso J, Angermeyer MC, Bernert S, et al: Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Suppl 420:47-54, 2004
34. Wang PS, Berglund P, Olfson M, et al: Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:603-613, 2005
35. Wang PS, Lane M, Olfson M, et al: Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62:629-640, 2005
36. Harris KM, Edlund MJ: Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services 56:954-959, 2005
37. Lahelma E, Laaksonen M, Martikainen P, et al: Multiple measures of socioeconomic circumstances and common mental disorders. Social Science and Medicine 63:1383-1399, 2006
38. Lepine JP, Gasquet I, Kovess V, et al: Prevalence and comorbidity of psychiatric disorders in the French general population [in French]. Encephale 31:182-194, 2005
39. Jorm AF: National surveys of mental disorders: are they researching scientific facts or constructing useful myths? Australian and New Zealand Journal of Psychiatry 40:830-834, 2006
40. Kessler RC, Chiu WT, Demler O, et al: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:617-627, 2005
41. Nelson CH, Park J: The nature and correlates of unmet health care needs in Ontario, Canada. Social Science and Medicine 62:2291-2300, 2006
42. Babor T, Brown J, Del Boca FK: Validity of self-reports in applied research on addictive behaviors: fact or fiction? Behavioral Assessment 12:5-31, 1990
43. Finch E, Strang J: Reliability and validity of self-report: on the importance of considering context. Drug and Alcohol Dependence 51:269, 1998
44. Skog OJ: The validity of self-reported drug use. British Journal of Addiction 87:539-548, 1992
45. Oakes JM, Rossi PH: The measurement of SES in health research: current practice and steps toward a new approach. Social Science and Medicine 56:769-784, 2003